ABHD17C, a metabolic and immune-related gene signature, predicts prognosis and anti-PD1 therapy response in pancreatic cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ABHD17C, a metabolic and immune-related gene signature, predicts prognosis and anti-PD1 therapy response in pancreatic cancer
Authors
Keywords
-
Journal
Discover Oncology
Volume 14, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-06-05
DOI
10.1007/s12672-023-00690-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic adaptation of lymphocytes in immunity and disease
- (2022) Nicole M. Chapman et al. IMMUNITY
- Metabolic regulation of somatic stem cells in vivo
- (2022) Corbin E. Meacham et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Tumor glycolysis, an essential sweet tooth of tumor cells
- (2022) Sumana Paul et al. SEMINARS IN CANCER BIOLOGY
- Role of LDH in tumor glycolysis: Regulation of LDHA by small molecules for cancer therapeutics
- (2022) Dolly Sharma et al. SEMINARS IN CANCER BIOLOGY
- Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity
- (2021) Ke Xu et al. SCIENCE
- Treatment landscape of metastatic pancreatic cancer
- (2021) Sara De Dosso et al. CANCER TREATMENT REVIEWS
- Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors
- (2021) Alison P. Klein Nature Reviews Gastroenterology & Hepatology
- Antibody therapy in pancreatic cancer: mAb-ye we’re onto something?
- (2021) Anna J. Boland et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Impact of cancer metabolism on therapy resistance – Clinical implications
- (2021) Ana Cristina Gonçalves et al. DRUG RESISTANCE UPDATES
- Metabolism of pancreatic cancer: paving the way to better anticancer strategies
- (2020) Cheng Qin et al. Molecular Cancer
- New Treatment Strategies for Metastatic Pancreatic Ductal Adenocarcinoma
- (2020) Ritu Raj Singh et al. DRUGS
- Pancreatic cancer
- (2020) Jonathan D Mizrahi et al. LANCET
- Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
- (2020) Yunzhen Qian et al. Journal of Hematology & Oncology
- Cutting out the fat: Site-specific deacylation of an ion channel
- (2020) Pedro J. del Rivero Morfin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular subtypes of pancreatic cancer
- (2019) Eric A. Collisson et al. Nature Reviews Gastroenterology & Hepatology
- Targeting metabolism to regulate immune responses in autoimmunity and cancer
- (2019) Chirag H. Patel et al. NATURE REVIEWS DRUG DISCOVERY
- Therapeutic developments in pancreatic cancer: current and future perspectives
- (2018) John P. Neoptolemos et al. Nature Reviews Gastroenterology & Hepatology
- Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options
- (2018) Derya Kabacaoglu et al. Frontiers in Immunology
- The Warburg Effect: How Does it Benefit Cancer Cells?
- (2016) Maria V. Liberti et al. TRENDS IN BIOCHEMICAL SCIENCES
- Fundamentals of cancer metabolism
- (2016) R. J. DeBerardinis et al. Science Advances
- How metabolites modulate metabolic flux
- (2015) Andre Wegner et al. CURRENT OPINION IN BIOTECHNOLOGY
- ABHD17 proteins are novel protein depalmitoylases that regulate N-Ras palmitate turnover and subcellular localization
- (2015) David Tse Shen Lin et al. eLife
- HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
- (2013) Gregg L. Semenza JOURNAL OF CLINICAL INVESTIGATION
- Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
- (2011) Sophia Y. Lunt et al. Annual Review of Cell and Developmental Biology
- Pancreatic cancer
- (2011) Audrey Vincent et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started